PIPELINE
Pipeline details
[IL2102] (SOS1 inhibitor) A perfect combination partner for KRAS inhibitor
[IL2102] (SOS1 inhibitor) A perfect combination partner for KRAS inhibitor DescriptionWe have identified potent, selective, orally av…
[IL2106] (CDK inhibitor) First-in-class CDK 4/6/12 inhibitor
[IL2106] (CDK inhibitor) First-in-class CDK 4/6/12 inhibitor Description<MoA>We identified first-in-class CDK 4/6/12 inhibitor …
[IL2106] CDK 12 inhibitor/Molecular glue/TPD
[IL2106] CDK 12 inhibitor/Molecular glue/TPD DescriptionWe have discovered a novel and potent molecular glue as an emerging therapeut…
[IL2112] (CXCR7 agonist) First in class anti-fibrosis for IPF and NASH
[IL2112] (CXCR7 agonist) First in class anti-fibrosis for IPF and NASH Description Oral available small molecule chemokine modul…
[IL2112] (CXCR7 agonist) First in class Neurodegeneration
[IL2112] (CXCR7 agonist) First in class Neurodegeneration Description Oral available small molecule chemokine modulator for treat…
[IL2401] (DAC) Degrader payloads for ADC
[IL2401] (DAC) Degrader payloads for ADCDescription A novel degrader payload series showed strong anti-cancer activities in various c…